Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results
Open Access
- 8 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (2), 249-251
- https://doi.org/10.1093/jac/dkp431
Abstract
The aim of this study was to evaluate the presence of carbapenemases in a Klebsiella pneumoniae collection and the performance of the modified Hodge test (MHT) to correctly identify this phenotype. Twenty-eight K. pneumoniae clinical isolates with reduced susceptibility to carbapenems were evaluated. Antimicrobial susceptibility and molecular typing were performed by agar dilution and PFGE, respectively. The MHT was performed using both standard and high inoculum of test organisms. Imipenem hydrolysis was investigated by spectrophotometric assays and carbapenemase-encoding genes were identified by PCR and amplicon sequencing. Porin loss was investigated by both PCR and SDS–PAGE. Susceptibility rates for imipenem, meropenem and ertapenem were 93%, 57% and 11%, respectively. The PFGE analysis showed seven unrelated genotypes. By testing standard inoculum and ertapenem or meropenem discs, 25% (n = 7) and 21% (n = 6) of the isolates were classified as carbapenemase producers, respectively. When a higher inoculum was employed, these rates increased to 54% (n = 15) and 43% (n = 12), respectively. No imipenem hydrolysis was detected. PCRs identified blaCTX-M in 27 (96%) isolates, of which 2 isolates also carried blaGES-1. SDS–PAGE and PCR assays revealed that all isolates had lost at least one outer membrane protein, except for a single isolate that was found to express both OmpK35 and OmpK36. False detection of carbapenemase production was observed by the MHT possibly as a result of extended-spectrum β-lactamase (ESBL) production coupled with porin loss as reported before. Clinical laboratories must be aware of this fact, especially in geographical areas where ESBL-producing isolates are highly prevalent.This publication has 11 references indexed in Scilit:
- Diversity of β-Lactamases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Isolates Causing Bloodstream Infections in BrazilAntimicrobial Agents and Chemotherapy, 2009
- Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UKJournal of Antimicrobial Chemotherapy, 2009
- Do CTX-M -lactamases hydrolyse ertapenem?Journal of Antimicrobial Chemotherapy, 2008
- The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination scheduleInternational Journal of Infectious Diseases, 2008
- Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.International Journal of Antimicrobial Agents, 2006
- Effects of Inoculum and β-Lactamase Activity in AmpC- and Extended-Spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella pneumoniae Clinical Isolates Tested by Using NCCLS ESBL MethodologyJournal of Clinical Microbiology, 2004
- Roles of β-Lactamases and Porins in Activities of Carbapenems and Cephalosporins against Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1999
- Porin expression in clinical isolates of Klebsiella pneumoniaeMicrobiology, 1999
- Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingJournal of Clinical Microbiology, 1995
- A SIMPLE TEST FOR PENICILLINASE PRODUCTION IN STAPHYLOCOCCUS AUREUSActa Pathologica Microbiologica Scandinavica Section B Microbiology and Immunology, 1971